Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.50 |
| ▸ | ITGAV | P06756 | 1/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27597841 | 0.89 | CHRM2 (0.69) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL8507959 | 0.89 | CHRM2 (0.58) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL4928781 | 0.88 | CHRM2 (0.71) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL472123 | 0.86 | SMN1; SMN2 (0.61) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL5940283 | 0.85 | CYP1A2 (0.54) | SMN1; SMN2RAB9AALOX15HPGDTDP1 | |
| SCHEMBL6302679 | 0.85 | CHRM2 (0.58) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL13606953 | 0.85 | CHRM2 (0.58) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL348655 | 0.82 | CHRM2 (0.78) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| SCHEMBL27726968 | 0.81 | CHRM2 (0.62) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 | |
| Acetic Acid SCHEMBL19585270 | 0.81 | SMN1; SMN2 (0.62) | SMN1; SMN2CHRM2NPC1RAB9AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009084737-A1 | COMPOUND HAVING ACTIVITY TO SUPPRESS DEGRANULATION AND CYTOKINE PRODUCTION AND USE THEREOF | INTERPROTEIN CORPORATION (JP) | 2009-07-09 | — | — | WO | claimed |
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | Indian Institute Of Science Education And Research Bhopal (IN) | 2026-05-12 | — | — | US | disclosed |
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2022-09-22 | — | — | US | disclosed |
| WO-2009084737-A1 | COMPOUND HAVING ACTIVITY TO SUPPRESS DEGRANULATION AND CYTOKINE PRODUCTION AND USE THEREOF | INTERPROTEIN CORPORATION (JP) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | PTMS, PA2G4, MAX | SMN1; SMN2 3108/4885CHRM2 2746/4885NPC1 2888/4885 |
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | DPYSL3, CD2BP2, PTMS | SMN1; SMN2 3324/4885CHRM2 1505/4885NPC1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.